Nancy J. Hutson - Jun 3, 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc (PHASQ)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PHASQ	Non-employee Director Stock Option (right to buy)	Award	$0	+14K		$0.00	14K	Jun 3, 2021	Common Stock	14K	$3.53	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the 2022 annual meeting, subject to the reporting person's continuous service through each such date